NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.

Authors: Scuteri, D., Guida, F., Boccella, S., Luongo, L., Maione, S., Tonin, P., Nicotera, P., Bagetta, G., Corasaniti, M. T.

Source: Biomedicine & pharmacotherapy 153, 113488 (2022). doi:10.1016/j.biopha.2022.113488

Subject Terms: info:eu-repo/classification/ddc/610, Aged, Cannabidiol: administration & dosage, Cannabidiol: adverse effects, Chronic Pain: drug therapy, Chronic Pain: etiology, Dementia: complications, Dementia: drug therapy, Double-Blind Method, Dronabinol: administration & dosage, Dronabinol: adverse effects, Drug Combinations, Humans, Oral Sprays, Psychomotor Agitation: drug therapy, Psychomotor Agitation: etiology, Randomized Controlled Trials as Topic, Agitation, CMAI, CONSORT, Cannabinoids, I-MOBID-2, Nabiximols, Pain, SPIRIT, Sativex®, Severe dementia, Cannabidiol, Dronabinol

Subject Geographic: DE

Relation: info:eu-repo/semantics/altIdentifier/issn/0300-0893; info:eu-repo/semantics/altIdentifier/issn/0753-3322; info:eu-repo/semantics/altIdentifier/pmid/pmid:36076584; info:eu-repo/semantics/altIdentifier/issn/1950-6007; https://pub.dzne.de/record/165171

Availability: https://pub.dzne.de/record/165171
https://pub.dzne.de/search?p=id:%22DZNE-2022-01473%22

A naturalistic examination of the perceived effects of cannabis on negative affect

Authors: Carrie Cuttler, Alexander Spradlin, Ryan J. McLaughlin

Source: Journal of Affective Disorders. 235:198-205

Subject Terms: Adult, Male, Anxiety - psychology, Anxiety, Stress, Dose-Response Relationship, 03 medical and health sciences, 0302 clinical medicine, Cannabidiol, Humans, Dronabinol, Affect - drug effects, Cannabidiol - administration & dosage, Dose-Response Relationship, Drug, Depression - drug therapy, Depression, Psychological - drug therapy, Perception - drug effects, Anxiety - drug therapy, Dronabinol - administration & dosage, 3. Good health, Psychological - psychology, Affect, Female, Perception, Drug, Depression - psychology, Stress, Psychological

File Description: pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/29656267

TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids

Authors: Andreas Traschütz, Stefanie N. Hayer, Benjamin Bender, Ludger Schöls, Saskia Biskup, Matthis Synofzik

Source: Parkinsonism & related disorders 60, 176-178 (2019). doi:10.1016/j.parkreldis.2018.09.031

Subject Terms: Adult, Male, 0301 basic medicine, Hyperkinesis: drug therapy, Dronabinol: administration & dosage, Consanguinity, Mitochondrial Proteins: genetics, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Peptide Elongation Factors: genetics, Movement Disorders: pathology, Humans, Cannabinoid Receptor Agonists: pharmacology, Medical Marijuana: administration & dosage, Hyperkinesis: genetics, Hyperkinesis: physiopathology, Movement Disorders: genetics, Hyperkinesis: pathology, Magnetic Resonance Imaging, Dronabinol: pharmacology, Movement Disorders: drug therapy, Cannabinoid Receptor Agonists: administration & dosage, Movement Disorders: physiopathology, Medical Marijuana: pharmacology, Subthalamic Nucleus: diagnostic imaging, Subthalamic Nucleus: pathology

Access URL: https://pub.dzne.de/record/140663

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

Authors: Johnson, Jeremy R, Lossignol, Dominique, Burnell-Nugent, Mary, Fallon, Marie T

Source: Journal of pain and symptom management

Subject Terms: Oral, Aerosols -- administration & dosage -- adverse effects, Great Britain -- epidemiology, Male, Pain Measurement -- drug effects, Pain, Administration, Oral, Terminal Care -- methods, Opioid -- adverse effects -- therapeutic use, Analgesics, Non-Narcotic -- administration & dosage -- adverse effects, Dose-Response Relationship, 03 medical and health sciences, 0302 clinical medicine, Belgium, Dronabinol -- administration & dosage -- adverse effects, Neoplasms, Belgium -- epidemiology, Humans, Dronabinol, Longitudinal Studies, Treatment Failure, Pain Measurement, Aerosols, Analgesics, Terminal Care, Intractable -- diagnosis -- drug therapy -- etiology, Dose-Response Relationship, Drug, Pain, Intractable -- diagnosis -- drug therapy -- etiology, Palliative Care, Drug Tolerance, Analgesics, Non-Narcotic, Middle Aged, Non-Narcotic -- administration & dosage -- adverse effects, Intractable Pain, Palliative Care -- methods, Analgesics, Opioid -- adverse effects -- therapeutic use, 3. Good health, Cancérologie, Analgesics, Opioid, Treatment Outcome, Administration, Female, Drug, Neoplasms -- complications -- diagnosis -- nursing, Follow-Up Studies

File Description: 1 full-text file(s): application/pdf

Access URL: http://www.jpsmjournal.com/article/S0885392412004393/pdf
https://pubmed.ncbi.nlm.nih.gov/23141881
https://dipot.ulb.ac.be/dspace/bitstream/2013/144691/1/Elsevier_128458.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144691

Drug vaping applied to cannabis: Is 'Cannavaping' a therapeutic alternative to marijuana?

Authors: Varlet, V., Concha-Lozano, Nicolas, Berthet, Aurélie, Plateel, Gregory, Favrat, B., De Cesare, M., Lauer, E., Augsburger, M., Thomas, A., Giroud, C.

Source: Sci Rep
Scientific reports.-2016
Scientific Reports, vol. 6, pp. 25599

Subject Terms: Cannabinoids, Vaping, Butanes/administration & dosage, Butanes/therapeutic use, Cannabinoids/administration & dosage, Cannabinoids/therapeutic use, Cannabis/chemistry, Dronabinol/administration & dosage, Dronabinol/therapeutic use, Electronic Nicotine Delivery Systems/instrumentation, Electronic Nicotine Delivery Systems/methods, Feasibility Studies, Humans, Marijuana Smoking, Medical Marijuana/administration & dosage, Medical Marijuana/therapeutic use, Reproducibility of Results, Vaping/instrumentation, Vaping/methods, Medical Marijuana, Electronic Nicotine Delivery Systems, Article, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Butanes, Dronabinol, Cannabis

File Description: application/pdf

Access URL: https://www.nature.com/articles/srep25599.pdf
https://pubmed.ncbi.nlm.nih.gov/27228348
https://sonar.ch/global/documents/137783
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C5A7CB0765F36
https://serval.unil.ch/notice/serval:BIB_C5A7CB0765F3
https://serval.unil.ch/resource/serval:BIB_C5A7CB0765F3.P001/REF.pdf

Two cases of 'cannabis acute psychosis' following the administration of oral cannabis

Authors: Favrat, B., Ménétrey, A., Augsburger, M., Rothuizen, L.E., Appenzeller, M., Buclin, T., Pin, M., Mangin, P., Giroud, C.

Source: BMC Psychiatry
BMC Psychiatry, Vol 5, Iss 1, p 17 (2005)
BMC psychiatry.-2005
BMC psychiatry, vol. 5, pp. 17

Subject Terms: Psychiatry, Adult, Male, Paranoid Disorders, Marijuana Abuse, Acute Disease, Administration, Oral, Depersonalization/chemically induced, Dronabinol/administration & dosage, Dronabinol/blood, Dronabinol/pharmacology, Hallucinogens/administration & dosage, Hallucinogens/blood, Hallucinogens/pharmacology, Humans, Marijuana Abuse/blood, Marijuana Abuse/etiology, Marijuana Smoking/epidemiology, Marijuana Smoking/psychology, Paranoid Disorders/chemically induced, Psychoses, Substance-Induced/blood, Psychoses, Substance-Induced/etiology, RC435-571, Case Report, Marijuana Smoking, Psychoses, Substance-Induced, 3. Good health, Psychiatry and Mental health, 03 medical and health sciences, 0302 clinical medicine, Depersonalization, Hallucinogens, Dronabinol

File Description: application/pdf

Access URL: https://bmcpsychiatry.biomedcentral.com/track/pdf/10.1186/1471-244X-5-17
https://pubmed.ncbi.nlm.nih.gov/15804348
https://doaj.org/article/20857a693d4845d5a8d10aef34655871
https://sonar.ch/global/documents/176884
https://serval.unil.ch/resource/serval:BIB_50A330F58CDE.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_50A330F58CDE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_50A330F58CDE4

TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids.

Authors: Traschuetz, Andreas, Hayer, Stefanie N, Bender, Benjamin, Schöls, Ludger, Biskup, Saskia, Synofzik, Matthis

Source: Parkinsonism & related disorders 60, 176-178 (2019). doi:10.1016/j.parkreldis.2018.09.031

Subject Terms: info:eu-repo/classification/ddc/610, Adult, Cannabinoid Receptor Agonists: administration & dosage, Cannabinoid Receptor Agonists: pharmacology, Consanguinity, Dronabinol: administration & dosage, Dronabinol: pharmacology, Humans, Hyperkinesis: drug therapy, Hyperkinesis: genetics, Hyperkinesis: pathology, Hyperkinesis: physiopathology, Magnetic Resonance Imaging, Male, Medical Marijuana: administration & dosage, Medical Marijuana: pharmacology, Mitochondrial Proteins: genetics, Movement Disorders: drug therapy, Movement Disorders: genetics, Movement Disorders: pathology, Movement Disorders: physiopathology, Peptide Elongation Factors: genetics, Subthalamic Nucleus: diagnostic imaging, Subthalamic Nucleus: pathology, Young Adult

Subject Geographic: DE

Relation: info:eu-repo/semantics/altIdentifier/pmid/pmid:30297209; info:eu-repo/semantics/altIdentifier/issn/1873-5126; info:eu-repo/semantics/altIdentifier/issn/1353-8020; https://pub.dzne.de/record/140663

Availability: https://pub.dzne.de/record/140663
https://pub.dzne.de/search?p=id:%22DZNE-2020-06985%22

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics.

Authors: Johnson, Jeremy R, Lossignol, Dominique, Burnell-Nugent, Mary, Fallon, Marie T

Source: Journal of pain and symptom management

Subject Terms: Cancérologie, Administration, Oral, Aerosols -- administration & dosage -- adverse effects, Analgesics, Non-Narcotic -- administration & dosage -- adverse effects, Opioid -- adverse effects -- therapeutic use, Belgium -- epidemiology, Dose-Response Relationship, Drug, Dronabinol -- administration & dosage -- adverse effects, Drug Tolerance, Female, Follow-Up Studies, Great Britain -- epidemiology, Humans, Longitudinal Studies, Male, Middle Aged, Neoplasms -- complications -- diagnosis -- nursing, Pain Measurement -- drug effects, Pain, Intractable -- diagnosis -- drug therapy -- etiology, Palliative Care -- methods, Terminal Care -- methods, Treatment Failure, Treatment Outcome

File Description: 1 full-text file(s): application/pdf

Relation: uri/info:doi/10.1016/j.jpainsymman.2012.07.014; uri/info:pmid/23141881; https://dipot.ulb.ac.be/dspace/bitstream/2013/144691/1/Elsevier_128458.pdf

Availability: https://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144691
https://dipot.ulb.ac.be/dspace/bitstream/2013/144691/1/Elsevier_128458.pdf

Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis - secondary publication / Effekten af det syntetiske cannabinoid, dronabinol, på central smerte hos patienter med dissemineret sklerose - sekundaerpublikation

Authors: Bacher Svendsen, K, Staehelin Jensen, T, Bach, F W

Source: Ugeskrift for Laeger. 167(25-31):2772